SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Debt History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Total Debt | ₹72 Cr | ₹83 Cr | ₹58 Cr | ₹12 Cr | ₹5.62 Cr |
What is the latest Total Debt ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Total Debt |
---|---|
Mar2024 | ₹72 Cr |
Mar2023 | ₹83 Cr |
Mar2022 | ₹58 Cr |
Mar2017 | ₹12 Cr |
Mar2016 | ₹5.62 Cr |
How is Total Debt of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2024 | ₹72 Cr | -12.86 | |
Mar2023 | ₹83 Cr | 43.94 | |
Mar2022 | ₹58 Cr | 364.15 | |
Mar2017 | ₹12 Cr | 121.47 | |
Mar2016 | ₹5.62 Cr | - |
Compare Total Debt of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹1,802.0 Cr | -10% | -2.7% | 48.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹399,249.0 Cr | -1.3% | -3.3% | 8.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,940.0 Cr | -1.5% | 0.8% | 42.3% | Stock Analytics | |
CIPLA | ₹121,197.0 Cr | -1.7% | 2.3% | -5.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,618.0 Cr | -1.6% | 8.4% | 10.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,250.0 Cr | -3.3% | -1.4% | 9.8% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -10% |
-2.7% |
48.3% |
SENSEX | 1.6% |
1% |
7% |
You may also like the below Video Courses